Stockreport

Aquestive Therapeutics Announces Regulatory Development for Anaphylm™ (dibutepinephrine) Sublingual Film and Provides Business Update [Yahoo! Finance]

Aquestive Therapeutics, Inc.  (AQST) 
Last aquestive therapeutics, inc. earnings: 3/11 04:30 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.aquestive.com/investor-relations
PDF Receives confirmation from FDA that Agency's review of Anaphylm NDA application is ongoing and no final FDA decision has been made Progresses global regulatory expans [Read more]